Silence Therapeutics plc
For the period ended Dec 31, 2025. Filed Mar 5, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 5, 2026
SLN$19.79+0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income (Loss)
(in thousands)
| Year ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Net Loss | $(88,612) | $(45,309) |
| Other comprehensive income (loss) net of tax: | ||
| Foreign exchange differences arising on consolidation of foreign operations (net of tax) | 8,804 | (1,055) |
| Total other comprehensive income/(loss) for the year | 8,804 | (1,055) |
| Total comprehensive loss for the year | $(79,808) | $(46,364) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.